Showing papers by "Yanfei Lan published in 2021"
TL;DR: The optimal prices and corresponding profits of the two retailers when applying and not applying blockchain are obtained, and it is suggested that it is not always beneficial for retailers to adopt blockchain technology in all situations.
37 citations
TL;DR: Wang et al. as mentioned in this paper considered two shareholding rates (forward and backward) and proposed three shareholding strategies (forward, backward and cross-shareholding) in a supplier-lead green supply chain to investigate the operation mechanism behind it.
Abstract: Observing the practical vertical shareholding phenomena in platform retailing, this paper considers two shareholding rates (forward and backward) and proposes three shareholding strategies (forward, backward and cross-shareholding) in a supplier-lead green supply chain to investigate the operation mechanism behind it. Shareholding’s impacts on green investment, prices and profits are provided and the players’ strategy preferences are discussed. We interestingly find that cross-shareholding can be joint optimal when the two shareholding rates are both sufficiently low and thereby Pareto region goes with it. Meanwhile, both the players’ performances can be further improved through certain coordinated ways.
15 citations
TL;DR: In this paper, the authors analyzed a pharmaceutical manufacturer encroachment strategy by taking into account the distinct features of drugs, in which drugs expenses are covered by medical insurance only in the physical channel and patients' channel preference is also considered.
Abstract: With the development of e-commerce, manufacturers have opportunities to sells products to consumers through direct channels in addition to independent retailers. Although manufacturers encroachment upon the retailing market of traditional goods has been extensively studied, there is a lack of research for manufacturers encroachment in a pharmaceutical supply chain. This paper analyzes a pharmaceutical manufacturer encroachment strategy by taking into account the distinct features of drugs, in which drugs expenses are covered by medical insurance only in physical channel and patients' channel preference is also considered. We find that under certain circumstance, the manufacturer encroachment may lead to a win-win outcome for both the manufacturer and the retailer, contradicting the conventional wisdom that manufacturer's encroachment into retail space is detrimental to the independent retailer. Additionally, the manufacturer is more likely to encroach when the incurred extra cost is sufficiently small, the perceived quality of the drug selling through the direct channel is sufficiently high and the out-of-pocket percentage cost of the drug selling in the physical channel is high. We further study the impact of manufacturer encroachment on social welfare and find that the introduction of encroachment decreases the social welfare when patients' perceived quality of the drug obtained through the online store is low and improves the social welfare when the perceived quality exceeds a certain threshold.